ReachMD
Be part of the knowledge.™Episodes 46-60 of 130
The When and How of Implementing New Anti-Neutrophil Therapies Into Standard Clinical Practice
MinuteCE®The When and How of Implementing New Anti-Neutrophil Therapies Into Standard Clinical Practice
Vortex Management: Multiprong and Individualized Treatment Approach
MinuteCE®Vortex Management: Multiprong and Individualized Treatment Approach
Caregiver Testimonial: A Day in the Life of the Bronchiectasis Patient
MinuteCE®Caregiver Testimonial: A Day in the Life of the Bronchiectasis Patient
Vortex Management: Diagnostic Algorithm for the PCP and Specialist
MinuteCE®Vortex Management: Diagnostic Algorithm for the PCP and Specialist
The Neutrophil and Neutrophil Serine Proteases (NSPs) in Non-CF Bronchiectasis (NCFBE)
MinuteCE®The Neutrophil and Neutrophil Serine Proteases (NSPs) in Non-CF Bronchiectasis (NCFBE)
Phenotyping the ILD-PH Patient To Determine Treatment Strategy
MinuteCE®Phenotyping the ILD-PH Patient To Determine Treatment Strategy
What Echo Aspects are Essential to PH Diagnosis?
MinuteCE®What Echo Aspects are Essential to PH Diagnosis?
Screening and Diagnosis of PAH: Cardiopulmonary Exercise Testing (CPET)
MinuteCE®Screening and Diagnosis of PAH: Cardiopulmonary Exercise Testing (CPET)
Case: A 54-Year-Old Woman With Progressive Dyspnea
MinuteCE®Case: A 54-Year-Old Woman With Progressive Dyspnea
Will Lowering the Hemodynamic Threshold for PH Impact “Discovery” of New Patients?
MinuteCE®Will Lowering the Hemodynamic Threshold for PH Impact “Discovery” of New Patients?
Why Should We Screen for PAH in Systemic Sclerosis Patients?
MinuteCE®Why Should We Screen for PAH in Systemic Sclerosis Patients?
